Company Search:
Advanced Search
Sponsored Links
Lumos Pharma Inc Company Snapshot
Lumos Pharma Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Lumos Pharma Inc with three other companies in this sector in UNITED STATES : Capricor Therapeutics Inc (2019 sales of $1.01 million ), Prothena Corporation PLC ($814,000.00 of which 100% was Pharmaceuticals), and Aptorum Group Ltd ($535,166.00 of which 100% was Pharmaceutical).

Sales Analysis. Sales fell dramatically in 2019: During the year ended December of 2019, sales at Lumos Pharma Inc were $936,000.00 . This is a sharp decrease of 92.5% versus 2018, when the company's sales were $12.47 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Lumos Pharma Inc
  Stock Performance Chart for Lumos Pharma Inc
  Stock Data: Recent Stock Performance:
  Current Price (10/23/2020): 14.40
(Figures in U.S. Dollars)
1 Week 1.2%   13 Weeks 3.9%  
4 Weeks -5.2%   52 Weeks 3.9%  
Lumos Pharma Inc Key Data:
  Ticker: LUMO Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 936,000
(Year Ending Jan 2020).
Employees: 21
  Currency: U.S. Dollars Market Cap: 119,410,424
  Fiscal Yr Ends: December Shares Outstanding: 8,293,312
  Share Type: Common Closely Held Shares: 2,060,781
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.